Huminsulin Normal Patronen Lilly (Insulin Human (Rdna))

Huminsulin Normal Patronen Lilly is indicated for the control of blood glucose in patients with diabetes mellitus.

• Type 1 diabetes mellitus
• Type 2 diabetes mellitus when other therapies are insufficient
• Adjunct to diet and exercise for glycemic management
• Use in multiple daily injection or insulin‑pump regimens
• May be considered during pregnancy under close medical supervision

• Insulin human binds to insulin receptors on cell membranes, activating the intrinsic tyrosine kinase activity of the receptor. This triggers a cascade involving IRS proteins, PI3‑K and Akt, leading to translocation of GLUT‑4 transporters to the plasma membrane and increased glucose uptake in muscle and adipose tissue. Concurrently, hepatic gluconeogenesis and glycogenolysis are suppressed, reducing endogenous glucose production and improving overall metabolic homeostasis.

Like other insulin preparations, Huminsulin Normal Patronen Lilly may be associated with adverse reactions, which can be classified by frequency.

Common

• Hypoglycemia (low blood glucose)
• Redness, swelling, or pain at the injection site
• Lipodystrophy or lipoatrophy at repeated injection sites
• Weight gain
• Mild allergic skin rash

Serious

• Severe hypoglycemia leading to loss of consciousness
• Anaphylactic reaction or angioedema
• Hypokalemia (low potassium levels)
• Significant edema or fluid retention
• Development of insulin resistance requiring dose escalation

Patients and healthcare providers should consider several safety points when using Huminsulin Normal Patronen Lilly.

• Regular self‑monitoring of blood glucose to detect hypoglycemia early
• Adjust doses in renal or hepatic impairment, as insulin clearance may be reduced
• Use with caution during pregnancy and lactation; consult a specialist
• Store cartridges refrigerated and protect from light; discard after the indicated in‑use period
• Do not use if there is a known hypersensitivity to human insulin or any excipients
• Educate patients on recognizing and managing hypoglycemia symptoms

Huminsulin Normal Patronen Lilly can interact with other medicines, influencing glucose control or insulin action.

Avoid

• Concurrent use of sulfonylureas or meglitinides, which may potentiate hypoglycemia
• High‑dose thiazide diuretics that can raise blood glucose levels
• Systemic corticosteroids that increase insulin resistance

Use with caution

• Non‑selective beta‑blockers, which may mask hypoglycemia signs
• ACE inhibitors or ARBs, as they can enhance insulin sensitivity and affect potassium
• Alcohol consumption, which can cause unpredictable glucose fluctuations
• Intensive physical exercise, requiring possible dose adjustments